136 related articles for article (PubMed ID: 35762561)
21. Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
Berger D; Folsom AR; Schreiner PJ; Chen LY; Michos ED; O'Neal WT; Soliman EZ; Alonso A
Maturitas; 2019 Jul; 125():5-10. PubMed ID: 31133217
[TBL] [Abstract][Full Text] [Related]
22. Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation.
Nopp S; Königsbrügge O; Kraemmer D; Pabinger I; Ay C
Eur J Intern Med; 2021 Jun; 88():35-42. PubMed ID: 33706979
[TBL] [Abstract][Full Text] [Related]
23. Echocardiographic measures of cardiac structure and function are associated with risk of atrial fibrillation in blacks: the Atherosclerosis Risk in Communities (ARIC) study.
Bekwelem W; Misialek JR; Konety S; Solomon SD; Soliman EZ; Loehr LR; Lopez FL; Fox ER; Mosley TH; Alonso A
PLoS One; 2014; 9(10):e110111. PubMed ID: 25330035
[TBL] [Abstract][Full Text] [Related]
24. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
[TBL] [Abstract][Full Text] [Related]
25. Association of physical activity with the incidence of atrial fibrillation in persons > 65 years old: the Atherosclerosis Risk in Communities (ARIC) study.
Fletcher G; Alam AB; Li L; Norby FL; Chen LY; Soliman EZ; Alonso A
BMC Cardiovasc Disord; 2022 Apr; 22(1):196. PubMed ID: 35473497
[TBL] [Abstract][Full Text] [Related]
26. Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
Norby FL; Soliman EZ; Chen LY; Bengtson LG; Loehr LR; Agarwal SK; Alonso A
Circulation; 2016 Aug; 134(8):599-610. PubMed ID: 27550968
[TBL] [Abstract][Full Text] [Related]
27. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
Rohatgi A; Patel P; Das SR; Ayers CR; Khera A; Martinez-Rumayor A; Berry JD; McGuire DK; de Lemos JA
Clin Chem; 2012 Jan; 58(1):172-82. PubMed ID: 22065155
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis.
Kubota Y; Alonso A; Heckbert SR; Norby FL; Folsom AR
Heart Lung Circ; 2019 Apr; 28(4):615-622. PubMed ID: 29685716
[TBL] [Abstract][Full Text] [Related]
29. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
30. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
31. Relation of Resting Heart Rate to Incident Atrial Fibrillation (From ARIC [Atherosclerosis Risk in Communities] Study).
Wang W; Alonso A; Soliman EZ; O'Neal WT; Calkins H; Chen LY; Diener-West M; Szklo M
Am J Cardiol; 2018 May; 121(10):1169-1176. PubMed ID: 29576236
[TBL] [Abstract][Full Text] [Related]
32. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
Lamprea-Montealegre JA; Zelnick LR; Shlipak MG; Floyd JS; Anderson AH; He J; Christenson R; Seliger SL; Soliman EZ; Deo R; Ky B; Feldman HI; Kusek JW; deFilippi CR; Wolf MS; Shafi T; Go AS; Bansal N;
J Am Heart Assoc; 2019 Aug; 8(15):e012200. PubMed ID: 31379242
[TBL] [Abstract][Full Text] [Related]
33. Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.
Lutsey PL; Norby FL; Alonso A; Cushman M; Chen LY; Michos ED; Folsom AR
J Thromb Haemost; 2018 Apr; 16(4):670-679. PubMed ID: 29431904
[TBL] [Abstract][Full Text] [Related]
34. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
Arenas de Larriva AP; Norby FL; Chen LY; Soliman EZ; Hoogeveen RC; Arking DE; Loehr LR; Alonso A
Int J Cardiol; 2017 Aug; 241():223-228. PubMed ID: 28427851
[TBL] [Abstract][Full Text] [Related]
35. Low-Carbohydrate Diets and Risk of Incident Atrial Fibrillation: A Prospective Cohort Study.
Zhang S; Zhuang X; Lin X; Zhong X; Zhou H; Sun X; Xiong Z; Huang Y; Fan Y; Guo Y; Du Z; Liao X
J Am Heart Assoc; 2019 May; 8(9):e011955. PubMed ID: 31020911
[TBL] [Abstract][Full Text] [Related]
36. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
Costa MD; Redline S; Soliman EZ; Goldberger AL; Heckbert SR
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H256-H271. PubMed ID: 32986961
[TBL] [Abstract][Full Text] [Related]
37. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
38. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
[TBL] [Abstract][Full Text] [Related]
39. Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
Li J; Agarwal SK; Alonso A; Blecker S; Chamberlain AM; London SJ; Loehr LR; McNeill AM; Poole C; Soliman EZ; Heiss G
Circulation; 2014 Mar; 129(9):971-80. PubMed ID: 24344084
[TBL] [Abstract][Full Text] [Related]
40. The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation.
Wei Y; Liu S; Yu H; Zhang Y; Gao W; Cui M; Li L
Mediators Inflamm; 2020; 2020():8360936. PubMed ID: 32904560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
